SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Hesp R, Hulme P, Williams D, Reeve J 1981 The relationship between changes in femoral bone density and calcium balance in patients with involutional osteoporosis treated with human parathyroid hormone fragment (hPTH 1–34). Metab Bone Dis Rel Res 2:331334.
  • 2
    Neer M, Slovik DM, Daly N, Potts JT Jr, Nussbaum SR 1993 Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol. Osteoporos Int 3:S204S205.
  • 3
    Reeve J, Meunier PJ, Parsons JA, Bernat M, Bijvoet OL, Courpron P, Edouard C, Klenerman L, Neer RM, Renier JC, Slovik D, Vismans FJ, Potts JT Jr 1980 Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: A multicentre trial. BMJ 280:13401344.
  • 4
    Reeve J, Arlot M, Bernat M, Charhon S, Edouard C, Slovik D, Vismans FJ, Meunier PJ 1981 Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: The influence of human parathyroid fragment (hPTH 1–34) therapy. Metab Bone Dis Rel Res 3:2330.
  • 5
    Mackey MS, Stevens ML, Ebert DC, Tressler DL, Combs KS, Lowry CK, Smith PN, McOsker JE 1995 The ferret as a small animal model with BMU-based remodeling for skeletal research. Bone 17:191S196S.
  • 6
    Jerome CP, Johnson CS, Lees CJ 1995 Effect of treatment for 3 months with human parathyroid hormone 1–34 peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis). Bone 17:415S420S.
  • 7
    Inoue J 1985 Bone changes with long-term administration of low doses of 1–34 human PTH in adult beagles. J Jpn Orthop Assoc 59:409427.
  • 8
    Boyce RW, Paddock CL, Franks AF, Jankowsky ML, Eriksen EF 1996 Effects of intermittent hPTH (1–34) alone and in combination with 1,25(OH)2D3 or risedronate on endosteal bone remodeling in canine cancellous and cortical bone. J Bone Miner Res 11:600613.
  • 9
    Delmas PD, Vergnaud P, Arlot ME, Pastoureau P, Meunier PJ, Nilssen MH 1995 The anabolic effect of human PTH (1–34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate—Is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system? Bone 16:603610.
  • 10
    Zhang L, Takahashi HE, Inoue J, Tanizawa T, Endo N, Yamamoto N, Hori M 1997 Effects of intermittent administration of low dose human PTH (1–34) on cancellous and cortical bone of lumbar vertebral bodies in adult beagles. Bone 21:501506.
  • 11
    Hirano T, Burr DB, Turner CH, Sato M, Cain RL, Hock JM 1999 Anabolic effects of human biosynthetic parathyroid hormone fragment (1–34) LY33334, on remodeling and mechanical properties of cortical bone in rabbits. J Bone Miner Res 14:536545.
  • 12
    Hirano T, Burr DB, Cain RL, Hock JM Changes in geometry and cortical porosity in adult, ovary-intact rabbits after 5 months treatment with LY333334 (HPTH 1–34). Calcif Tissue Int (in press).
  • 13
    Schock CC, Noyes FR, Villaneuva AR 1972 Measurement of Haversian bone remodeling by means of tetracycline labelling in rib of rhesus monkeys. Henry Ford Hosp Med J 20:131144.
  • 14
    Hodsman AB, Fraher LJ, Watson PH, Ostbye T, Stitt LW, Adachi JD, Taves DH, Drost D 1997 A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone vs. cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 82:620628.
  • 15
    Finkelstein JS, Klibanski A, Arnold AI, Toth TL, Hornstein MD, Neer RM 1998 Prevention of estrogen deficiency-related bone loss with human parathyroid hormone (1–34). JAMA 280:10671073.
  • 16
    Lindsay R, Nieves J, Formica C, Henneman E, Woelfert L, Shen V, Dempster D, Cosman F 1997 Randomized controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet 350:550555.
  • 17
    Brommage R, Hotchkiss CE, Lees CJ, Stancill MW, Hock JM, Jerome CP 1999 Daily treatment with human recombinant parathyroid hormone 1–34 for one year increases bone mass in ovariectomized monkeys. J Clin Endocrinol Metab 84:37573763.
  • 18
    Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: Standardization of nomenclature, symbols, and units. J Bone Miner Res 6:595610.
  • 19
    Carter DR, Hayes WC 1977 The compressive behavior of bone as a two-phase porous structure. J Bone Joint Surg (Am) 59A:954962.
  • 20
    Turner CH, Burr DB 1993 Basic biomechanical measurements of bone: A tutorial. Bone 14:595608.
  • 21
    Hodsman A-B, Steer MB, Fraher LJ Drost DJ 1991 Bone densitometric and histomorphometric responses to sequential human parathyroid hormone (1–38) and salmon calcitonin in osteoporotic patients. Bone Miner 14:6783.
  • 22
    Ejersted C, Andreassen TT, Oxlund H, Jorgensen PH, Bak B, Haggblad J, Torring O, Nilssen MH 1993 Human parathyroid hormone (1–34) and (1–84) increase the mechanical strength and thickness of cortical bone in rats. J Bone Miner Res 8:10971101.
  • 23
    Oxlund H, Ejersted C, Andreassen TT, Torring O, Nilssen MH 1993 Parathyroid hormone (1–34) and (1–84) stimulate cortical bone formation both from periosteum and endosteum. Calcif Tissue Int 53:394399.
  • 24
    Liu C-C, Kalu DN 1990 Human parathyroid hormone (1–34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats. J Bone Miner Res 4:449458.
  • 25
    Wronski TJ, Yen CF 1994 Anabolic effects of parathyroid hormone on cortical bone in ovariectomized rats. Bone 15:5158.
  • 26
    Baumann BD, Wronski TJ 1995 Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats. Bone 16:247253.
  • 27
    Mosekilde L, Danielsen CC, Søgaard CH, McOsker JE, Wronski TJ 1995 The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strength-assessed in a sexually mature, ovariectomized rat model. Bone 16:223230.
  • 28
    Ejersted C, Oxlund H, Andreassen TT 1998 Bisphosphonate maintains parathyroid hormone (1–34)-induced cortical bone mass and mechanical strength in old rats. Calcif Tissue Int 62:316322.
  • 29
    Shen V, Birchman R, Xu R, Otter M, Wu D, Lindsay R, Dempster DW 1995 Effects of reciprocal treatment with estrogen and estrogen plus parathyroid hormone on bone structure and strength in ovariectomized rats. J Clin Invest 96:23312338.
  • 30
    Mellish RWE, Shen V, Birchman R, Meng XW, Horbert W, Dempster D, Lindsay R 1990 Quantitative analysis of trabecular bone in ovariectomized rats after intermittent administration of low dose human parathyroid hormone fragment (1–34) and 17β-estradiol. In: ChristiansenC, OvergaardK (eds.) Handestrykkeriet Aalborg APS, Aalborg, Denmark, pp. 13351337.
  • 31
    Gunness-Hey M, Hock JM 1989 Loss of the anabolic effect of PTH on bone after discontinuation of hormone in rats. Bone 10:447452.
  • 32
    Yamamoto N, Takahashi HE, Tanizawa T, Fujimoto R, Hara T, Tanaka S 1993 Maintenance of bone mass by physical exercise after discontinuation of intermittent hPTH (1–34) administration. Bone Miner 23:333342.
  • 33
    Vradenburg M, Metcalfe A, Dietrich J, MacLachlan R, Smith SY, Bare S, Kimmel DB 1997 Dose effect of parathyroid hormone (1–84) on bone formation and porosity in cortical bone of rhesus monkeys. J Bone Miner Res 12;:S1:S236.
  • 34
    Jerome CP, Hansen L 1996 Cortical bone remodeling in femur and radius is stimulated by parathyroid hormone treatment in ovariectomized female cynomolgus macaques. J Bone Miner Res 11;:S1:S152.